Clin2
NCT07359807Possibly a fitNot yet recruiting

Comparing two drug-coated balloons for blocked leg arteries

Popliteal Artery DiseaseSuperficial Femoral Artery Disease

Part of Heart & circulation, Injuries & trauma clinical trials.

This study is comparing a new treatment using a sirolimus-coated balloon to an existing paclitaxel-coated balloon to open up narrowed or blocked arteries in the leg. The goal is to improve blood flow and reduce leg pain, and this trial will help see if the new treatment is just as good or better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
478 people
Ages
21 years and older
Study type
Interventional

Who can take part

  • You must be at least 21 years old.
  • You have leg pain with walking or worse symptoms (pain at rest or skin wounds) due to a blocked leg artery.
  • The blocked area in your leg must be new or narrowed again (but not previously stented) and show at least 70% narrowing.
  • The narrowed section must be between 40 mm and 200 mm long.
  • You have not had prior vascular surgery (like bypass or atherectomy) or a major amputation on the affected leg.
  • You are not on dialysis and have not had a stroke or heart attack within the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06734221Recruiting
Testing a paclitaxel-coated balloon for leg artery disease

This trial tests a special balloon coated with a drug (paclitaxel) to open blocked leg arteries, aiming to improve blood flow and reduce symptoms like leg pain when walking. It is for people with moderate to severe leg artery disease who have not had prior stents or bypass in the treated area.

Chrzanów, Malopolska
NCT04511234Recruiting
Sirolimus-coated balloon vs standard balloon for leg artery narrowing

This trial compares two balloon treatments used during a procedure to open blocked or narrowed arteries in the thigh and behind the knee. It tests whether the sirolimus-coated balloon works better at keeping the artery open than a standard balloon.

Singapore
NCT06182397Recruiting
Drug-coated balloon for leg artery blockages below the knee

This trial tests a special balloon coated with sirolimus (a drug that helps prevent arteries from re-closing) versus a standard balloon for opening blocked arteries below the knee in people with severe leg pain or foot wounds. The goal is to see if the drug-coated balloon works better to keep the artery open longer.

Scottsdale, Arizona
NCT04511247Recruiting
Drug-coated balloon for artery disease below the knee

This trial tests a drug-coated balloon to open narrowed or blocked arteries in the lower leg (below the knee) and help them stay open. It’s meant for people with significant symptoms, to reduce re-narrowing after treatment.

Singapore
NCT07425171Recruiting
Testing a drug-coated balloon for long leg artery blockages

This trial is testing a special balloon coated with the drug paclitaxel to open up long blockages in the leg artery (femoropopliteal). The goal is to see if it is safe and effective for improving blood flow and symptoms like pain or ulcers.

Suwon, Gyeonggi-do
NCT07406308Not yet recruiting· Early Phase 1
Balloon with or without plaque removal for blocked leg arteries

This study compares two ways to open a completely blocked artery in the leg: using a paclitaxel-coated balloon alone, or first removing some blockage with a special device (debulking) before using the balloon. It aims to see which approach gives better long-term results for people with chronic leg artery blockages.

Beijing

Hear when a new Popliteal Artery Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.